Solid Dispersion of Kaempferol: Formulation Development, Characterization, and Oral Bioavailability Assessment


Kaempferol (KPF), an important flavonoid, has been reported to exert antioxidant, anti-inflammatory, and anticancer activity. However, this compound has low water solubility and hence poor oral bioavailability. This work aims to prepare a solid dispersion (SD) of KPF using Poloxamer 407 in order to improve the water solubility, dissolution rate, and pharmacokinetic properties KPF. After optimization, SDs were prepared at a 1:5 weight ratio of KPF:carrier using the solvent method (SDSM) and melting method (SDMM). Formulations were characterized by Fourier transform infrared spectroscopy (FTIR), X-ray diffractometry (XRD) analysis, differential scanning calorimetry (DSC), and scanning electron microscopy (SEM). The solubility in water of carried-KPF was about 4000-fold greater than that of free KPF. Compared with free KPF or the physical mixture, solid dispersions significantly increased the extent of drug release (approximately 100% within 120 min) and the dissolution rate. Furthermore, after oral administration of SDMM in rats, the area under the curve (AUC) and the peak plasma concentration (Cmax) of KPF from SDMM were twofold greater than those of free KPF (p < 0.05). In conclusion, SD with Poloxamer 407 is a feasible pharmacotechnical strategy to ameliorate the dissolution and bioavailability of KPF.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8


  1. 1.

    Calderon-Montano JM, Burgos-Moron E, Perez-Guerrero C, Lopez-Lazaro M. A review on the dietary flavonoid kaempferol. Mini-Rev Med Chem. 2011;11:298–344.

    CAS  Article  Google Scholar 

  2. 2.

    Devi KP, Malar DS, Nabavi SF, Sureda A, Xiao J, Nabavi SM, et al. Kaempferol and inflammation: from chemistry to medicine. Pharmacol Res. 2015;99:1–10.

    CAS  Article  Google Scholar 

  3. 3.

    Chen AY, Chen YC. A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention. Food Chem. 2013;138:2099–107.

    CAS  Article  PubMed  Google Scholar 

  4. 4.

    Rothwell JA, Day AJ, Morgan MR. Experimental determination of octanol-water partition coefficients of quercetin and related flavonoids. J Agric Food Chem. 2005;53:4355–60.

    CAS  Article  Google Scholar 

  5. 5.

    Xie Y, Luo H, Duan J, Hong C, Ma P, Li G, et al. Phytic acid enhances the oral absorption of isorhamnetin, quercetin, and kaempferol in total flavones of Hippophae rhamnoides L. Fitoterapia. 2014;93:216–25.

    CAS  Article  PubMed  Google Scholar 

  6. 6.

    Vo CL, Park C, Lee BJ. Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs. Eur J Pharm Biopharm. 2013;85:799–813.

    CAS  Article  Google Scholar 

  7. 7.

    Chiou WL, Riegelman S. Pharmaceutical applications of solid dispersion systems. J Pharm Sci. 1971;60:1281–302.

    CAS  Article  Google Scholar 

  8. 8.

    Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm. 2000;50:47–60.

    CAS  Article  PubMed  Google Scholar 

  9. 9.

    Meng F, Gala U, Chauhan H. Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques. Drug Dev Ind Pharm. 2015;41:1401–15.

    CAS  Article  Google Scholar 

  10. 10.

    Vasconcelos T, Marques S, das Neves J, Sarmento B. Amorphous solid dispersions: rational selection of a manufacturing process. Adv Drug Deliv Rev. 2016;100:85–101.

    CAS  Article  Google Scholar 

  11. 11.

    Mustapha O, Kim KS, Shafique S, Kim DS, Jin SG, Seo YG, et al. Comparison of three different types of cilostazol-loaded solid dispersion: physicochemical characterization and pharmacokinetics in rats. Colloids Surf B Biointerfaces. 2017;154:89–95.

    CAS  Article  Google Scholar 

  12. 12.

    Chen ZP, Sun J, Chen HX, Xiao YY, Liu D, Chen J, et al. Comparative pharmacokinetics and bioavailability studies of quercetin, kaempferol and isorhamnetin after oral administration of Ginkgo biloba extracts, Ginkgo biloba extract phospholipid complexes and Ginkgo biloba extract solid dispersions in rats. Fitoterapia. 2010;81:1045–52.

    CAS  Article  Google Scholar 

  13. 13.

    Wang W, Kang Q, Liu N, Zhang Q, Zhang Y, Li H, et al. Enhanced dissolution rate and oral bioavailability of Ginkgo biloba extract by preparing solid dispersion via hot-melt extrusion. Fitoterapia. 2015;102:189–97.

    Article  Google Scholar 

  14. 14.

    Li W, Yi S, Wang Z, Chen S, Xin S, Xie J, et al. Self-nanoemulsifying drug delivery system of persimmon leaf extract: optimization and bioavailability studies. Int J Pharm. 2011;420:161–71.

    CAS  Article  PubMed  Google Scholar 

  15. 15.

    Zhao G, Duan J, Xie Y, Lin G, Luo H, Li G, et al. Effects of solid dispersion and self-emulsifying formulations on the solubility, dissolution, permeability and pharmacokinetics of isorhamnetin, quercetin and kaempferol in total flavones of Hippophae rhamnoides L. Drug Dev Ind Pharm. 2013;39:1037–45.

    CAS  Article  PubMed  Google Scholar 

  16. 16.

    Duan J, Dang Y, Meng H, Wang H, Ma P, Li G, et al. A comparison of the pharmacokinetics of three different preparations of total flavones of Hippophae rhamnoides in beagle dogs after oral administration. Eur J Drug Metab Pharmacokinet. 2016;41:239–49.

    CAS  Article  Google Scholar 

  17. 17.

    Tzeng CW, Yen FL, Wu TH, Ko HH, Lee CW, Tzeng WS, et al. Enhancement of dissolution and antioxidant activity of kaempferol using a nanoparticle engineering process. J Agric Food Chem. 2011;59:5073–80.

    CAS  Article  Google Scholar 

  18. 18.

    Kumar A, Gupta GK, Khedgikar V, Gautam J, Kushwaha P, Changkija B, et al. In vivo efficacy studies of layer-by-layer nano-matrix bearing kaempferol for the conditions of osteoporosis: a study in ovariectomized rat model. Eur J Pharm Biopharm. 2012;82:508–17.

    CAS  Article  Google Scholar 

  19. 19.

    Zhang K, Gu L, Chen J, Zhang Y, Jiang Y, Zhao L, et al. Preparation and evaluation of kaempferol-phospholipid complex for pharmacokinetics and bioavailability in SD rats. J Pharm Biomed Anal. 2015;114:168–75.

    CAS  Article  Google Scholar 

  20. 20.

    Telange D, Patil A, Pethe A, Tatode A, Sridhar A, Dave V. Kaempferol-phospholipid complex: formulation, and evaluation of improved solubility, in vivo bioavailability, and antioxidant potential of kaempferol. 2016.

  21. 21.

    Colombo M, Melchiades GL, Figueiró F, Battastini AMO, Teixeira HF, Koester LS. Validation of an HPLC-UV method for analysis of Kaempferol-loaded nanoemulsion and its application to in vitro and in vivo tests. J Pharm Biomed Anal. 2017;145:831–7.

    CAS  Article  PubMed  Google Scholar 

  22. 22.

    Nemitz MC, Yatsu FK, Bidone J, Koester LS, Bassani VL, Garcia CV, et al. A versatile, stability-indicating and high-throughput ultra-fast liquid chromatography method for the determination of isoflavone aglycones in soybeans, topical formulations, and permeation assays. Talanta. 2015;134:183–93.

    CAS  Article  Google Scholar 

  23. 23.

    Higuchi T, Connors KA. Phase solubility techniques. Adv Anal Chem Instrum. 1965;4:117–212.

    CAS  Google Scholar 

  24. 24.

    Khan KA. The concept of dissolution efficiency. J Pharm Pharmacol. 1975;27:48–9.

    CAS  Article  Google Scholar 

  25. 25.

    Moore JW, Flanner HH. Mathematical comparison of dissolution profiles. Pharm Technol. 1996;20:64–74.

    Google Scholar 

  26. 26.

    Zhang Y, Huo M, Zhou J, Xie S. PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comput Methods Prog Biomed. 2010;99:306–14.

    Article  Google Scholar 

  27. 27.

    Eloy JO, Marchetti JM. Solid dispersions containing ursolic acid in Poloxamer 407 and PEG 6000: a comparative study of fusion and solvent methods. Powder Technol. 2014;253:98–106.

    CAS  Article  Google Scholar 

  28. 28.

    Simonazzi A, Davies C, Cid AG, Gonzo E, Parada L, Bermudez JM. Preparation and characterization of Poloxamer 407 solid dispersions as an alternative strategy to improve benznidazole bioperformance. J Pharm Sci. 2018;107:2829–36.

    CAS  Article  Google Scholar 

  29. 29.

    Dugar RP, Gajera BY, Dave RH. Fusion method for solubility and dissolution rate enhancement of ibuprofen using block copolymer poloxamer 407. AAPS PharmSciTech. 2016;17:1428–40.

    CAS  Article  PubMed  Google Scholar 

  30. 30.

    Chaudhari SP, Dugar RP. Application of surfactants in solid dispersion technology for improving solubility of poorly water soluble drugs. J Drug Delivery Sci Technol. 2017;41:68–77.

    CAS  Article  Google Scholar 

  31. 31.

    Tambe A, Pandita N. Enhanced solubility and drug release profile of boswellic acid using a poloxamer-based solid dispersion technique. J Drug Delivery Sci Technol. 2018;44:172–80.

    CAS  Article  Google Scholar 

  32. 32.

    Dumortier G, Grossiord JL, Agnely F, Chaumeil JC. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res. 2006;23:2709–28.

    CAS  Article  Google Scholar 

  33. 33.

    Rowe RC, Sheskey PJ, Owen SC. Handbook of pharmaceutical excipients. London: Pharmaceutical Press London; 2006.

    Google Scholar 

  34. 34.

    Li B, Konecke S, Harich K, Wegiel L, Taylor LS, Edgar KJ. Solid dispersion of quercetin in cellulose derivative matrices influences both solubility and stability. Carbohydr Polym. 2013;92:2033–40.

    CAS  Article  Google Scholar 

  35. 35.

    Mehanna MM, Motawaa AM, Samaha MW. In sight into tadalafil - block copolymer binary solid dispersion: mechanistic investigation of dissolution enhancement. Int J Pharm. 2010;402:78–88.

    CAS  Article  Google Scholar 

  36. 36.

    Ali W, Williams AC, Rawlinson CF. Stochiometrically governed molecular interactions in drug: poloxamer solid dispersions. Int J Pharm. 2010;391:162–8.

    CAS  Article  Google Scholar 

  37. 37.

    Khan AW, Kotta S, Ansari SH, Sharma RK, Ali J. Enhanced dissolution and bioavailability of grapefruit flavonoid Naringenin by solid dispersion utilizing fourth generation carrier. Drug Dev Ind Pharm. 2015;41:772–9.

    CAS  Article  Google Scholar 

  38. 38.

    Cavallari C, Gonzalez-Rodriguez M, Tarterini F, Fini A. Image analysis of lutrol/gelucire/olanzapine microspheres prepared by ultrasound-assisted spray congealing. Eur J Pharm Biopharm. 2014;88:909–18.

    CAS  Article  PubMed  Google Scholar 

  39. 39.

    Kawabata Y, Wada K, Nakatani M, Yamada S, Onoue S. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. Int J Pharm. 2011;420:1–10.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  40. 40.

    FDA. Guidance for industry: dissolution testing of immediate release solid oral dosage forms. Rockville, MD. 1997.

  41. 41.

    FDA. Guidance for industry: SUPAC-MR: modified release solid oral dosage forms scale-up and postapproval changes: chemistry, manufacturing, and controls; in vitro dissolution testing and in vivo bioequivalence documentation. Rockville, MD. 1997.

  42. 42.

    FDA. Guidance for industry: waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system. Rockville, MD. 2000.

  43. 43.

    Xing J, Chen X, Zhong D. Absorption and enterohepatic circulation of baicalin in rats. Life Sci. 2005;78:140–6.

    CAS  Article  Google Scholar 

  44. 44.

    DuPont MS, Day AJ, Bennett RN, Mellon FA, Kroon PA. Absorption of kaempferol from endive, a source of kaempferol-3-glucuronide, in humans. Eur J Clin Nutr. 2004;58:947–54.

    CAS  Article  Google Scholar 

  45. 45.

    Zhang WD, Wang XJ, Zhou SY, Gu Y, Wang R, Zhang TL, et al. Determination of free and glucuronidated kaempferol in rat plasma by LC-MS/MS: application to pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci. 2010;878:2137–40.

    CAS  Article  Google Scholar 

  46. 46.

    Zhang Q, Zhang Y, Zhang Z, Lu Z. Sensitive determination of kaempferol in rat plasma by high-performance liquid chromatography with chemiluminescence detection and application to a pharmacokinetic study. J Chromatogr B. 2009;877:3595–600.

    CAS  Article  Google Scholar 

Download references


This study was financially supported by CAPES-MEC, Brazil (Network Nanobiotec—grant no. 902/2009 and PROCAD—grant no. 552457/2011-6), CNPq (grant no. 453927/2014-9), and FAPERGS (Edital PqG 2017-T.O. 17/2551-0001043-4 and 17/2551-0000 970-3). M.C. thanks CAPES for her scholarship.

Author information



Corresponding author

Correspondence to Letícia Scherer Koester.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Colombo, M., de Lima Melchiades, G., Michels, L.R. et al. Solid Dispersion of Kaempferol: Formulation Development, Characterization, and Oral Bioavailability Assessment. AAPS PharmSciTech 20, 106 (2019).

Download citation


  • kaempferol
  • Poloxamer 407
  • solid dispersion
  • dissolution
  • bioavailability